ISPOR Europe 2026 8-11 November
The Visible Analytics and Newmarket Strategy team will be in Vienna this November and we look forward to meeting you there.Come meet us at our booth #305 and join us at one of our sessions.
See our full list of activities for ISPOR Europe 2026 below.
Monday 9 November
Issue panel
Beware (Non-Proportional) Hazard! Alternative Routes for Dealing with Time-Varying Treatment Effects in Evidence Synthesis for Health Technology Assessment (HTA) Decision Making [13:45-14:45]
Moderator: Prof. Keith R Abrams, University of Warwick, UK
Speakers: David Phillippo, PhD, University of Bristol, UK; Prof. Rhiannon K Owen, Swansea University,UK; Shannon Cope, MSc, Unpuzzle HEOR, Vancouver, Canada
Poster session 1
12:30 - 13:30 Discussion period
Retractions of Network Meta-Analyses: A Systematic Review [SA16]
Eric Julian Manalastas1, Juliette C Thompson1, Aditi Hombali1, David A Scott1
1Visible Analytics Ltd, Oxford, UK
Beyond Uncertainty: A Cross-Agency Review of HTA Appraisals of Early-Phase Trials in aNSCLC
Urshita Pandit1, Noemi Muszbek2, Federico Manevy3, Kostas Papadakis4
1Visible Analytics Ltd, Oxford, UK; 2Visible Analytics Ltd, Reading, UK; 3Bayer Consumer Care AG, Basel, Switzerland; 4Bayer, Adliswil, Switzerland.
Tuesday 10 November
Other breakout session
Patient engagement in economic modelling: bridging the gap between what’s measured and what matters [10:30-11:30]
Moderator: Neil Hawkins, MSc, PhD, MBA, CStat, University of Glasgow, UK
Speakers: Ariel Yuhan Ong, MD, Moorfields Eye Hospital NHS Foundation Trust, UK; Matthew Selby, BSc, Ocular Melanoma UK, UK; Noemi Muszbek, MSc, Visible Analytics Ltd, UK
Wednesday 11 November
Poster session 5
9:00 - 10:00 Discussion period
Seeing the Full Picture: Structured Model Conceptualisation to Incorporate the Dual Burden of Tumour Progression and Visual Morbidity in Choroidal Melanoma [EE714]
Alisha Angdembe1, Noemi Muszbek1, Ross Goldstein2, Joseph Birkett2
1Visible Analytics Ltd, Oxford, UK, 2Aura Biosciences, Boston, MA, USA
